BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 11377665)

  • 21. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

  • 22. Generic HIV drugs will widen US treatment net.
    Maxmen A
    Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
    [No Abstract]   [Full Text] [Related]  

  • 23. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 24. Access to antiretrovirals in South Africa.
    Reprod Health Matters; 2001 Nov; 9(18):180. PubMed ID: 11803902
    [No Abstract]   [Full Text] [Related]  

  • 25. Less expensive ZDV on the way.
    AIDS Read; 2005 Nov; 15(11):573-4. PubMed ID: 16329175
    [No Abstract]   [Full Text] [Related]  

  • 26. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 27. Global fund decides to promote use of generic drugs.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):58-9. PubMed ID: 14740604
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress at last? South Africa relents on HIV drugs.
    Huff B
    GMHC Treat Issues; 2003; 17(7-8):16, 15. PubMed ID: 14686317
    [No Abstract]   [Full Text] [Related]  

  • 29. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 30. Hope for South Africa--at last.
    Lancet; 2003 Aug; 362(9383):501. PubMed ID: 12932376
    [No Abstract]   [Full Text] [Related]  

  • 31. Canada's plan to sell generic drugs to developing countries is threatened.
    Spurgeon D
    BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
    [No Abstract]   [Full Text] [Related]  

  • 32. Cut-rate AIDS.
    Golden F
    Time; 2001 Mar; 157(11):68. PubMed ID: 11276822
    [No Abstract]   [Full Text] [Related]  

  • 33. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 34. Policy shift. Bush's AIDS plan includes condom distribution, generic drugs.
    AIDS Policy Law; 2003 Feb; 18(3):5. PubMed ID: 12635615
    [No Abstract]   [Full Text] [Related]  

  • 35. "No turning back" on cheap AIDS drugs for poor nations, UN vows.
    Silversides A
    CMAJ; 2003 Nov; 169(10):1067. PubMed ID: 14609992
    [No Abstract]   [Full Text] [Related]  

  • 36. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 37. Cheap HIV drugs for developing countries.
    Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
    [No Abstract]   [Full Text] [Related]  

  • 38. Costs of eliminating HIV in South Africa have been underestimated.
    Wagner B; Blower S
    Lancet; 2010 Sep; 376(9745):953-4. PubMed ID: 20851250
    [No Abstract]   [Full Text] [Related]  

  • 39. Tobias, W.H.O. at odds over drug standards.
    Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
    [No Abstract]   [Full Text] [Related]  

  • 40. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.